Seizure prophylaxis in an animal model of epilepsy by dietary fluoxetine supplementation

Epilepsy Research

Volumn 74, Issue 1, 2007, Pages 19-27

  Richman, Alyssa ^a   Heinrichs, Stephen C ^a  

^a Department of Psychology ^*  (United States)

Author keywords

Antidepressant; Locomotor activity; Seizure; Serotonin; Tail suspension handling

Indexed keywords

FLUOXETINE; GLUCOSE; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CELL DENSITY; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIETARY INTAKE; DISEASE MODEL; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG EFFICACY; EPILEPSY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; LOCOMOTION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PARIETAL LOBE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; WEIGHT CHANGE;

ANIMAL FEED; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; GENETIC PREDISPOSITION TO DISEASE; HANDLING (PSYCHOLOGY); HINDLIMB SUSPENSION; MICE; MICE, INBRED STRAINS; SEIZURES; SELF ADMINISTRATION; SEROTONIN UPTAKE INHIBITORS;

EID: 33947103648     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2006.11.007     Document Type: Article

References (58)

1. Balcombe J.P., Barnard N.D., et al. Laboratory routines cause animal stress. Contemp. Top Lab. Anim. Sci. 43 6 (2004) 42-51
2. Berridge K.C. Food reward: brain substrates of wanting and liking. Neurosci. Biobehav. Rev. 20 1 (1996) 1-25
3. Cabrera-Vera T.M., and Battaglia G. Prenatal exposure to fluoxetine (Prozac) produces site-specific and age-dependent alterations in brain serotonin transporters in rat progeny: evidence from autoradiographic studies. J. Pharmacol. Exp. Ther. 286 3 (1998) 1474-1481
4. Compan V., Zhou M., et al. Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. J. Neurosci. 24 2 (2004) 412-419
5. Dailey J.W., Mishra P.K., et al. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci. 50 4 (1992) 319-326
6. Dailey J.W., and Naritoku D.K. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem. Pharmacol. 52 9 (1996) 1323-1329
7. Dailey J.W., Yan Q.S., et al. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci. 58 4 (1996) 259-266
8. Drage M.G., and Heinrichs S.C. Phenotyping the untouchables: environmental enhancement of behavioral and physiological activation in seizure-prone El mice. Epilepsy Behav. 6 1 (2005) 35-42
9. Dubuc P.U., and Peterson C.M. Ineffectiveness of parenteral fluoxetine or RU-486 to alter long-term food intake, body weight or body composition of genetically obese mice. J. Pharmacol. Exp. Ther. 255 3 (1990) 976-979
10. Eells J.B., Clough R.W., et al. Comparative fos immunoreactivity in the brain after forebrain, brainstem, or combined seizures induced by electroshock, pentylenetetrazol, focally induced and audiogenic seizures in rats. Neuroscience 123 1 (2004) 279-292
11. El Hage W., Peronny S., et al. Impaired memory following predatory stress in mice is improved by fluoxetine. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 1 (2004) 123-128
12. Fenoglio K.A., Chen Y., et al. Neuroplasticity of the hypothalamic-pituitary-adrenal axis early in life requires recurrent recruitment of stress-regulating brain regions. J. Neurosci. 26 9 (2006) 2434-2442
13. Ferrero A.J., Cereseto M., et al. Chronic treatment with fluoxetine decreases seizure threshold in naive but not in rats exposed to the learned helplessness paradigm: Correlation with the hippocampal glutamate release. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 5 (2005) 678-686
14. Gomez R., Huber J., et al. Acute effect of different antidepressants on glycemia in diabetic and non-diabetic rats. Braz. J. Med. Biol. Res. 34 1 (2001) 57-64
15. Harvey B.H., and Bouwer C.D. Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors. Clin. Neuropharmacol. 23 2 (2000) 90-97
16. Hashiguchi W., Nagatomo I., et al. Influences of caffeine to nitric oxide production and zonisamide concentration in the brain of seizure-susceptible EL mice. Psychiatry Clin. Neurosci. 55 4 (2001) 319-324
17. Heinrichs S.C., and Seyfried T.N. Behavioral seizure correlates in animal models of epilepsy: a road map for assay selection, data interpretation, and the search for causal mechanisms. Epilepsy Behav. 8 1 (2006) 5-38
18. Heisler L.K., Kanarek R.B., et al. Fluoxetine decreases fat and protein intakes but not carbohydrate intake in male rats. Pharmacol. Biochem. Behav. 58 3 (1997) 767-773
19. Hernandez E.J., Williams P.A., et al. Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia 43 11 (2002) 1337-1345
20. Hiramatsu M. Brain monoamine levels and E1 mouse convulsions. Folia Psychiatr. Neurol. Jpn. 35 3 (1981) 261-266
21. Ishida N., Kasamo K., et al. Epileptic seizure of El mouse initiates at the parietal cortex: depth EEG observation in freely moving condition using buffer amplifier. Brain Res. 608 1 (1993) 52-57
22. Jobe P.C., and Browning R.A. The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav. 7 4 (2005) 602-619
23. 2+ channel blocking potencies. Brain Res. Bull. 67 1/2 (2005) 126-132
24. King J.T., and LaMotte C.C. El mouse as a model of focal epilepsy: a review. Epilepsia 30 3 (1989) 257-265
25. Kordik C.P., and Reitz A.B. Pharmacological treatment of obesity: therapeutic strategies. J. Med. Chem. 42 2 (1999) 181-201
26. Leussis, M.P., Heinrichs, S.C., in press. Temporal ontogeny of seizure circuit activation prior to the onset of seizure susceptibility in EL mice. Neuroscience.
27. Lim, C.E., Turner, L.H., et al., in press. Short-term social recognition memory deficit and altered social and physiological stressor reactivity in seizure-susceptible El mice. Seizure.
28. Lopez-Meraz M.L., Gonzalez-Trujano M.E., et al. 5-HT1A receptor agonists modify epileptic seizures in three experimental models in rats. Neuropharmacology 49 3 (2005) 367-375
29. Macedo D.S., Santos R.S., et al. Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality. Epilepsy Behav. 5 6 (2004) 852-856
30. Mantis J.G., Centeno N.A., et al. Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr. Metab. (Lond.) 1 1 (2004) 11
31. McFadyen-Leussis M., and Heinrichs S.C. Handling of EL/Suz mice elicits differential fos activation in the locus ceruleus during development. Society for Neuroscience Annual Meeting. San Diego, California (2004)
32. McFadyen-Leussis M.P., and Heinrichs S.C. Seizure-prone EL/Suz mice exhibit physical and motor delays and heightened locomotor activity in response to novelty during development. Epilepsy Behav. 6 3 (2005) 312-319
33. Mraovitch S., and Calando Y. Interactions between limbic, thalamo-striatal-cortical, and central autonomic pathways during epileptic seizure progression. J. Comp. Neurol. 411 1 (1999) 145-161
34. Murashima Y.L., Kassamo K., et al. Developmental and seizure-related regional differences in immediate early gene expression and GABAergic abnormalities in the brain of EL mice. Epilepsy Res. 26 1 (1996) 3-14
35. Murashima Y.L., Suzuki J., et al. In: Benjamin S.M. (Ed). Ictogenesis and Epileptogenesis in Epileptic Mutant EL Mice. Focus on Epilepsy Research (2004), Nova Science Publishers, Inc., New York 139-198
36. Murashima Y.L., Yoshii M., et al. Ictogenesis and epileptogenesis in EL mice. Epilepsia 43 Suppl. 5 (2002) 130-135
37. Mutoh K., Ito M., et al. Depth EEG in mutant epileptic E1 mice: demonstration of secondary generalization of the seizure from the hippocampus. Electroencephalogr. Clin. Neurophysiol. 86 3 (1993) 205-212
38. Nakamoto Y., Nakayama S., et al. Cerebral uptake of [14C]deoxyglucose during the entire seizure and the recovery period in an El mouse. Epilepsy Res. 5 1 (1990) 43-48
39. Nemeroff C.B., Mayberg H.S., et al. VNS Therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology. 31 7 (2006) 1345-1355
40. Pascual, J., Heinrichs, S.C., in press. Olfactory neophobia and seizure susceptibility phenotypes in an animal model of epilepsy are normalized by impairment of brain corticotropin releasing factor. Epilepsia.
41. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, San Diego
42. Pericic D., Lazic J., et al. Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice. Brain Res. 1033 1 (2005) 90-95
43. Rho J.M., Kim D.W., et al. Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Res. 37 3 (1999) 233-240
44. Sarkisian M.R. Overview of the current animal models for human seizure and epileptic disorders. Epilepsy Behav. 2 3 (2001) 201-216
45. Schatzberg A.F. New indications for antidepressants. J. Clin. Psychiatry 61 Suppl. 2 (2000) 9-17
46. Schridde U., and van Luijtelaar G. The role of the environment on the development of spike-wave discharges in two strains of rats. Physiol. Behav. 84 3 (2005) 379-386
47. Seyfried T.N., and Glaser G.H. A review of mouse mutants as genetic models of epilepsy. Epilepsia 26 2 (1985) 143-150
48. Seyfried T.N., Greene A.E., et al. Caloric restriction and epilepsy: historical perspectives, relationship to the ketogenic diet, and analysis in epileptic EL mice. In: Stafstrom C.E., and Rho J.M. (Eds). Epilepsy and the Ketogenic Diet (2004), Humana Press 247-264
49. Silva R.C.B., and Brandao M.L. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol. Biochem. Behav. 65 2 (2000) 209-216
50. Stafstrom C.E., and Bough K.J. The ketogenic diet for the treatment of epilepsy: a challenge for nutritional neuroscientists. Nutr. Neurosci. 6 2 (2003) 67-79
51. Stevenson C.W., and Gratton A. Basolateral amygdala modulation of the nucleus accumbens dopamine response to stress: role of the medial prefrontal cortex. Eur. J. Neurosci. 17 6 (2003) 1287-1295
52. Sur C., Betz H., et al. Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 73 1 (1996) 217-231
53. Suzuki J., and Nakamoto Y. Abnormal plastic phenomena of sensory-precipitated epilepsy in the mutant El mouse. Exp. Neurol. 75 2 (1982) 440-452
54. Suzuki J., Nakamoto Y., et al. Local cerebral glucose utilization in epileptic seizures of the mutant El mouse. Brain Res. 266 2 (1983) 359-363
55. Tecott L.H., Sun L.M., et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 374 6522 (1995) 542-546
56. Tupal S., and Faingold C.L. Evidence supporting a role of serotonin in modulation of sudden death induced by seizures in DBA/2 mice. Epilepsia 47 1 (2006) 21-26
57. Turner, L.H., Lim, C.E., et al., in press. Anti-social and seizure susceptibility phenotypes in an animal model of epilepsy are normalized by impairment of brain corticotropin releasing factor. Epilepsy Behav.
58. Ugale R.R., Mittal N., et al. Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice. Brain Res. 1023 1 (2004) 102-111